Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial

2022; Elsevier BV; Volume: 10; Issue: 8 Linguagem: Inglês

10.1016/s2213-2600(22)00087-x

ISSN

2213-2619

Autores

Jingxin Li, Shipo Wu, Xiling Guo, Rong Tang, Baoying Huang, Xiaoqin Chen, Yin Chen, Lihua Hou, Jingxian Liu, Jin Zhong, Hongxing Pan, Fengjuan Shi, Xiaoyu Xu, Zhuo-Pei Li, Xiaoyin Zhang, Lunbiao Cui, Wenjie Tan, Wei Chen, Fengcai Zhu, Jingxin Li, Shipo Wu, Xiling Guo, Rong Tang, Baoying Huang, Xiaoqin Chen, Yin Chen, Lihua Hou, Jingxian Liu, Jin Zhong, Hongxing Pan, Fengjuan Shi, Xiaoyu Xu, Zhuo-Pei Li, Xiaoyin Zhang, Lunbiao Cui, Wenjie Tan, Wei Chen, Fengcai Zhu, Baoying Huang, Jin-Bo Gou, Weixue Si, Xue Wang, Xiaolong Zhao, Tao Zhu,

Tópico(s)

Vaccine Coverage and Hesitancy

Referência(s)